SOS, the guanine nucleotide exchange factor for Ras, becomes phosphorylated on serine and threonine residues following stimulation of cells with growth factors. These phosphorylations may play a role in negative feedback of Ras stimulation and have been shown to be mediated in part by the MAP kinases Erk-1 and Erk-2. Here we show that in addition to MAP kinase, a major mitogen activated kinase for SOS is p90 Rsk-2, a downstream target of MAP kinase. p90 Rsk-2 phosphorylates SOS in an in gel assay and also in solution in vitro. The ability of p90 Rsk-2 to phosphorylate SOS increases greatly following EGF treatment of PC12 cells and is blocked by expression of N17 Ras or treatment with the MEK inhibitor PD98059. Phosphopeptide mapping revealed that the sites phosphorylated by p90 Rsk-2 in vitro were also phosphorylated in intact cells in response to EGF treatment. Several major sites of in vivo phosphorylation correlated with p90 Rsk-2 phosphorylation sites rather than MAP kinase sites. It is therefore likely that p90 Rsk-2 plays an important role in the down regulation of the Ras activation pathway through SOS.
Introduction
Ras is a member of a family of small GTP binding proteins which is central in controlling cell growth and dierentiation processes in response to extracellular signals. Growth factor stimulation of cells leads to the activation of Ras into its GTP bound state, via either the inhibition of GTPase activating proteins, such as p120 GAP and neuro®bromin (Downward et al., 1990) or alternatively, via the activation of guanine nucleotide exchange factors such as SOS and Ras-GRF, (Buday and Downward, 1993b; Medema et al., 1993) .
Genetic evidence from Drosophila as well as biochemical data from mammalian cells indicate that the activation of Ras and subsequent signalling pathways occurs through a series of protein-protein interactions involving the activated receptor, the adaptor molecules Shc and Grb2 and the exchange factor SOS. The mechanism by which SOS activates Ras is still unclear since the intrinsic guanine nucleotide exchange activity of SOS is not enhanced by growth factor stimulation (Buday and Downward, 1993a) . The evidence to date suggests that translocation of the Grb2-SOS complex to the plasma membrane may be sucient to lead to Ras activation since either constitutively membrane targeted mutants (Quilliam et al., 1994; Aronheim et al., 1994) or conditional membrane targeted alleles of SOS (Holsinger et al., 1995) can directly lead to Ras activation. In addition, studies done in Drosophila and in mammalian cells indicate that sequences contained within the amino-terminal region of SOS, including the PH and DBL domains, may be involved in stimulating the exchange activity Karlovich et al., 1995; Byrne et al., 1996) . In contrast, sequences contained within the proline-rich carboxy-terminal region of SOS which mediate binding to Grb2, may be involved in down regulating the exchange activity towards Ras (Wang et al., 1995; Karlovich et al., 1995; McCollam et al., 1995) . Therefore a combination of proper localization of SOS at the membrane and subsequent binding of activators and eectors may be necessary for full activation of the exchange factor in vivo.
Coincident with growth factor stimulation, SOS undergoes serine/threonine phosphorylation which is manifested as a retardation in its mobility on SDS polyacrylamide gels (Rozakis Adcock et al., 1993; Gale et al., 1993; Burgering et al., 1993; Skolnik et al., 1993) . Results obtained using speci®c inhibitors of the MAP kinase kinase, MEK (Langlois et al., 1995; Waters et al., 1995a) , or cAMP which blocks MAPK activation in response to growth factors (Burgering et al., 1993; Corbalan-Garcia et al., 1996a) , would indicate that the p42 and p44 MAP kinases are most likely responsible for SOS phosphorylation. Consistent with these observations, the proline-rich carboxy-terminal region of SOS contains a number of MAPK consensus sites, some of which have been shown to be phosphorylated by this kinase both in vitro and in vivo (Cherniack et al., 1994; Corbalan-Garcia et al., 1996b; Rozakis-Adcock et al., 1995) . By analogy to S. cerivisiae where Cdc25 phosphorylation is involved in down regulation of the Ras pathway (Gross et al., 1992) , MAP kinase phosphorylation of SOS in mammalian cells is thought to play a similar role. However, while no change in SOS exchange activity has yet been demonstrated in response to MAP kinase phosphorylation, the binding to Grb2 and Shc has been shown to be altered. Indeed in response to dierent stimuli such as insulin or EGF, the resulting phosphorylation of SOS is thought to play a negative feedback role on the Ras pathway, by causing the dissociation of Grb2 from SOS (Corbalan-Garcia et al., 1996a; Waters et al., 1995b; Cherniack et al., 1995) or alternatively, dissociation of the Grb2-SOS binary complex from the receptor (Rozakis- Adcock et al., 1995; Klarlund et al., 1995; Langlois et al., 1995; Por®ri and McCormick, 1996) . While MAP kinase phosphorylation may partially be responsible for these eects on SOS, recently it has been shown that a kinase other than MAP kinase is also involved in SOS phosphorylation. Furthermore in vivo phosphopeptide mapping of SOS has indicated that not all sites can be accounted for by MAP kinase phosphorylation (Corbalan-Garcia et al., 1996b; Rozakis-Adcock et al., 1995) . In addition, Holt et al. have also shown by expressing MKP-1, the MAPK phosphatase, that a kinase other than MAPK can induce a mobility shift in SOS as well as its dissociation from Grb2 in response to insulin (Holt et al., 1996a) .
In the rat pheochromocytoma cell line PC12, Ras is activated in response to EGF and NGF through complex formation involving tyrosine phosphorylated Shc, Grb2 and SOS (Basu et al., 1994) . As with growth factor stimulation of ®broblast cells, EGF and NGF treatment of PC12 cells leads to SOS phosphorylation and a shift in its mobility on SDS polyacrylamide gels. As an approach to identifying kinases other than MAP kinase that may be involved in SOS phosphorylation in PC12 cells, a combination of in-gel kinase assays and anion exchange chromatography was employed. This strategy enabled us to demonstrate that in addition to MAP kinase, p90 Rsk-2 is involved in SOS phosphorylation in PC12 cells and may be important in down regulation of the growth factor response.
Results

Two kinase activities can renature and phosphorylate SOS in the gel
As an approach to identifying kinases that may be involved in SOS phosphorylation in the rat PC12 cell line, a combination of in-gel kinase assays (where full length SOS is co-polymerized in the gel) and anion exchange chromatography was employed. In-gel kinase assays where dierent substrates can be copolymerized in the gel have proven to be a powerful method by which protein kinases can be identi®ed and further characterized (Kameshita and Fujisawa, 1989) . Total lysates from PC12 cells which had been serum starved overnight or stimulated with EGF, were resolved on SDS ± PAGE with either full length epitope tagged Glu-hSOS, or myelin basic protein (MBP) co-polymerized in the gel. After overnight renaturation and kinase assay, two dierent growth factor inducible kinase activities were found on the SOS gel; a kinase doublet at 43 kDa, and a kinase at approximately 90 kDa (Figure 1a) . The kinases at 43 kDa, present in both the SOS gel and the MBP gel ( Figure 1a and b) , are likely to be p42 Erk-2 and p44 Erk-1 as these growth factor inducible kinases are known to utilize both these proteins as substrates (Cherniack et al., 1994; Corbalan-Garcia et al., 1996b; Rozakis-Adcock et al., 1995; Boulton et al., 1991) . In contrast, the 90 kDa growth factor inducible kinase was only seen in the SOS gel and therefore appeared to be speci®c for this substrate. Indeed, at the same relative position in the MBP gel, a basal activity was detected which did not increase upon growth factor stimulation ( Figure 1b) . In addition, a larger 120 kDa protein kinase was found to renature and eciently phosphorylate MBP in the gel. These results indicate that the in-gel kinase assays can re-capitulate growth factor inducible events (such as activation of MAPK), and that in addition to MAP kinase, at least one other growth factor inducible kinase can phosphorylate SOS in PC12 cell lysates.
The 90 kDa kinase activity can be resolved from MAPK by anion exchange chromatography
In order to further characterize the 90 kDa SOS kinase activity, PC12 lysates were resolved by anion exchange chromatography. We had previously shown using Gst-SOS fusions as substrates in a soluble kinase assay, that¯ow through fractions as well as those eluting prior to 0.2 M NaCl, did not contain any SOS phophorylating activity (data not shown). Therefore, lysates from PC12 cells which had been stimulated with EGF were fractionated over a Biorad Q cartridge and individual fractions eluting between 0.2 M and 0.4 M NaCl assayed for SOS in-gel kinase activity. As shown in Figure 2a , the 90 kDa protein kinase eluted between 0.21 and 0.26 M NaCl just prior to the renaturable MAPK activity (eluting between 0.27 and 0.32 M NaCl, see Figure 2a and b). When assayed for Glu-SOS phosphorylating activity in solution (Figure 2c ), two peaks of activity could be detected which corresponded to the major peaks of renaturable kinase activities. That is, a ®rst peak of SOS phosphorylating activity could be detected between fractions 36 and 41 (corresponding to the 90 kDa in gel kinase peak), and another peak between fractions 45 and 47 (corresponding to the tail end of the renaturable MAP kinase activity). Notably, the elution pro®le of MAP kinase as detected by Western blotting was broader than that corresponding to the elution pro®les as measured by in-gel and in vitro kinase assays. These discrepancies may re¯ect that the dierent phosphorylation forms of MAP kinase have dierent speci®c activities for SOS phosphorylation in these assays. This has also been observed for p90 Rsk-2 with respect to CREB phosphorylation (Xing et al., 1996) . Thus as measured by two dierent assays, there appears to be more than one SOS kinase activity in PC12 cells. (7), or stimulated (+) with EGF (50 ng/ml for 2 min), were resolved by SDS ± PAGE on gels prepared with either (a) epitope tagged Glu-SOS, or (b) myelin basic protein (MBP), and subjected to an in-gel kinase assay
The 90 kDa SOS kinase is Ras dependent and MEK dependent
Given that the observed in gel kinase activities were growth factor inducible, we sought to determine if the activation of Ras was required, and if so, where along the pathway the 90 kDa kinase resided. To this end, the eects of a dominant negative Ras mutant (N17 Ras) and the MEK activation inhibitor PD98059 were evaluated on the 90 kDa SOS in gel kinase activity ( Figure 3 ). Equal amounts of lysates derived from PC12 cells which had been left unstimulated (Figure 3a) , stimulated with EGF (Figure 3b ), or pre-treated with PD98059 and then stimulated with EGF ( Figure 3c ) were loaded onto an anion exchange column (Bio-Rad Q cartridge), and individual fractions eluting between 0.2 and 0.32 M NaCl assayed for SOS in gel kinase activity. As before, the 90 kDa kinase activity was stimulated upon EGF treatment (over 15-fold as measured by phosphoimager quantitation (Figure 3e ).
This stimulation was almost completely inhibited by addition of the MEK activation inhibitor PD98059 (Figure 3c ), as it was in PC12 cells stably expressing the dominant negative N17 Ras mutant (Figure 3d ). Therefore the 90 kDa SOS kinase appeared to be downstream of Ras and MEK in the Ras pathway.
There are few 90 kDa protein kinases which are known to be growth factor inducible, Ras dependent and MEK dependent. Amongst possible kinases, p90 Rsk appeared to be a prime candidate. Not only has it been shown to be a growth factor inducible, Ras dependent and MEK dependent kinase (Wood et al., 1992; Alessi et al., 1995) , it has also been shown to renature and autophosphorylate in in-gel kinase assays (Scimeca et al., 1992; Toshihiro et al., 1996) . More recently, p90 Rsk-2 has also been shown to phosphorylate a CREB peptide using this assay (Xing et al., 1996) . When we tested puri®ed p90 Rsk-2 for in-gel kinase activity, we found that not only could it autophosphorylate, but its activity was enhanced approximately ®vefold when SOS was co-polymerized in the gel suggesting it could use this protein as a substrate (data not shown). Finally, when individual fractions from the anion exchange columns were analysed by Western blotting with anti-Rsk-2 antibodies, the SOS in-gel kinase activity and a protein immunologically related to p90 Rsk-2 were found to co-elute ( Figure 3 , lower panels of a to d, and data not shown).
The 90 kDa SOS protein kinase is p90 Rsk-2
In order to establish the identity of the 90 kDa in-gel kinase, a series of immunodepletion experiments were carried out. A chromatography fraction that had been positive for the 90 kDa in-gel kinase activity was subjected to several rounds of immunoprecipitation using antibodies directed to either p90 Rsk-2, p70 S6 kinase or p42 Erk-2. As shown in Figure 4 , only the Rsk-2 antibody was capable of immunoprecipitating an in-gel kinase activity of approximately 90 kDa from the fraction (see 1st, 2nd and 3rd round IP). In addition, only the Rsk-2 antibody could successfully immunodeplete the SOS in-gel kinase activity from the fraction (see fraction after IP). Three isoforms of Rsk have been identi®ed to date: however, Rsk-1 was shown to elute in the¯ow through fractions of a Mono Q column, while Rsk-3 elutes between 0.34 and 0.35 M NaCl (Xing et al., 1996) . In addition since Rsk-1 is mainly restricted to haematopoietic cell types (Alcorta et al., 1989; Moller et al., 1994) , and Rsk-3 has been suggested to be MEK independent (Zhao et al., 1995) , these data indicate that the growth factor inducible ingel kinase activity is likely the Rsk-2 isoform.
p90 Rsk and MAPK phosphorylate distinct regions in the carboxy tail of SOS p90 Rsk is an arginine directed kinase which will phosphorylate serine residues within the minimal recognition sequence arg-X-X-ser (Erikson, 1991) however, the enzyme prefers a basic residue at position n-5 with respect to the phosphorylation site to ®t the consensus arg/lys-X-arg-X-X-ser (Leighton et al., 1995) . MAPK is a proline directed kinase which will phosphorylate serine or threonine residues within the consensus sequence pro-X-ser/thr-pro (Clark- Lewis et al., 1991; Gonzalez et al., 1991) . The carboxyterminal tail of SOS is proline rich and contains a number of MAPK phosphorylation sites, most of which have been mapped in vitro and in vivo (Corbalan-Garcia et al., 1996b; Rozakis- Adcock et al., 1995) . Examination of the SOS sequence shows ®ve Rsk minimal recognition sequences (R-X-X-S), one of which at position 1161 in the carboxy terminal tail of hSOS (residue 1164 in mSOS) ®ts the full consensus R/K-X-R-X-X-S. In order to compare MAPK and Rsk phosphorylation of SOS, full-length epitope-tagged Glu-hSOS, or Gst-mSOS fusions were used as substrates in in vitro kinase assays. The Gst-SOS1A fusion encompasses the full-length carboxyterminal region of SOS from amino acid residues 1135 to 1336, while the Gst-SOS70 fusion contains only the proximal sequences of the carboxy-terminal region of SOS from residues 1135 to 1205 (see Figure 5a and Figure 8 ). As shown in Figure 5b and c, at comparable MBP kinase levels, p90 Rsk led to greater phosphorylation of SOS (in particular Gst-SOS1A) compared with MAPK. More importantly, while both MAPK and Rsk could phosphorylate GluhSOS and the full-length carboxy-terminal fusion of SOS (Gst-SOS1A), only Rsk could phosphorylate the proximal sequences of this region (Gst-SOS70). These results indicate that the two kinases phosphorylate distinct regions of the carboxy terminus of SOS and may therefore provide dierent functional roles in the regulation of SOS.
Rsk and MAPK both contribute to SOS phosphorylation in vivo
To analyse the contribution of the dierent kinases to SOS phosphorylation in vivo, tryptic peptide maps were generated from in vivo labelled SOS ( Figure 6 ) and
Immunodepletion of the SOS in-gel kinase activity with antibodies directed against p90 Rsk-2. An FPLC fraction containing the 90 kDa SOS in-gel kinase activity was subjected to three sequential rounds of immunoprecipitations using an antiRsk-2 antibody. Anti-Erk-2 and anti-p70S6 kinase antibodies were used as controls, as well as protein G. The relative activity of the 90 kDa SOS kinase immunoprecipitated with the Rsk antibody and remaining in the supernatants after immunodepletion was determined by SOS in-gel kinase assays. The total immunoprecipitates (100%) from each round were loaded onto the gel (labelled 1st, 2nd and 3rd round IP'), versus 6% of the original fraction used before the immunoprecipitations (labelled`original fraction') and 6% of the fraction after the immunoprecipitations (labelled`fraction after IP') compared to those generated from in vitro phosphorylated SOS (Figures 5 and 7) .
To this end, PC12 cells were in vivo labelled overnight and either kept unstimulated, stimulated with EGF for 2 min, or pre-treated with the MEK inhibitor PD98059 and stimulated with EGF. Endogenous SOS was immunoprecipitated from the lysates and tryptic phosphopeptides maps generated. As shown in Figure 6a , SOS was basally phosphorylated in unstimulated PC12 cells, and this phosphorylation was greatly enhanced upon EGF stimulation. Furthermore, and consistent with MAPK and Rsk being involved in SOS phosphorylation, treatment with PD98059 completely blocked EGF induced SOS phosphorylation in vivo. The peptide maps derived from in vivo labelled SOS (from EGF stimulated cells) revealed a number of peptides which were also seen in the in vitro peptides maps. In addition, and as suggested by the in vitro phosphorylation of SOS by the two dierent kinases (Figure 5b) , the peptides maps indicated that Rsk and MAPK phosphorylated mainly distinct sites in SOS (Figure 7b) .
Overall, when Rsk was used to phosphorylate full length Glu-hSOS (Figure 7e ), two major phosphopeptides (e and g) and two minor peptides (b and i) were generated which were also seen in vivo, albeit at dierent stoichiometries. Peptide e which corresponded to a major peptide in vivo, was the only peptide generated when either Gst-SOS1A or Gst-SOS70 were used as substrates for Rsk (Figure 7 f, g amd h). The only common Rsk consensus site which may be shared between these two Gst fusions is residue 1161 in hSOS1 which ®ts the full consensus for Rsk (R-X-R-X-X-S) (see Figure 8 ). Its phosphorylation must therefore give rise to peptide e. Since this peptide lies between two proline-rich regions involved in binding the SH3 domain of Grb2 (Sastry et al., 1995) , phosphorylation of this region by Rsk may therefore play an important functional role in the down regulation of SOS. Finally, peptides b, g and i were only phosphorylated when using full length SOS as a substrate, these sites must reside outside the sequences contained within the Gst fusions. These peptides could therefore correspond to phosphorylation of residues 1064 or 1134 in the carboxy tail of hSOS, or to residues 68 or 571 in the amino terminal region, which all ®t the minimal sequence motif for Rsk (R-X-X-S).
When MAPK was used to phosphorylate full length SOS, a larger number of peptides were generated, some of which were observed in vivo. In particular peptides d, f and l were phosphorylated when Gst-SOS1A was used as a substrate and peptides e and j when Glu-SOS was used as a substrate (Figure 7 a and c) . The stoichiometry of phosphorylation was again quite dierent in vivo and in vitro. In particular peptide j which was a major MAPK site in vitro, was only weakly phosphorylated in vivo and conversely peptide f which was weakly phosphorylated in vitro corresponded to a major in vivo phosphopeptide. Taken together these results suggest that both Rsk-2 and MAPK can contribute to SOS phosphorylation in PC12 cells.
Discussion
In response to growth factor stimulation, SOS is phosphorylated on serine and threonine residues and undergoes a shift in its mobility in SDS polyacrylamide gels (Rozakis Adcock et al., 1993; Gale et al., 1993; 
Figure 5 Rsk-2 and MAPK phosphorylate dierent regions of the carboxy tail of SOS. Partially puri®ed Rsk-2 and puri®ed MAPK were used in in vitro kinase assays with dierent SOS substrates. (a) schematic representation of the dierent SOS substrates; full length epitope tagged Glu-hSOS, Gst-mSOS1A (amino acid residues 1135 to 1336) and Gst-mSOS70 (encompassing amino acid residues 1135 to 1205), (b) in vitro phosphorylation of the SOS substrates, Gst and MBP by p90 Rsk-2 or MAPK, (c) relative activity of Rsk-2 and MAPK on the dierent substrates as measured by phosphoimager analysis (average of two independent experiments) Burgering et al., 1993; Skolnik et al., 1993) . By making use of an in-gel kinase assay approach combined with FPLC, we have sought to identify kinase activities involved in SOS phosphorylation in the rat PC12 cell line. While the in-gel kinase technique relies on the ability of kinases to renature in the gel and therefore limits the number of potential kinases, it does oer some speci®city by varying the nature of the substrate co-polymerized in the gel. Indeed Cano et al. identi®ed the anisomycin-activated p45 and p55 kinases as murine MAPKAP kinase-2 by co-polymerizing poly Glu/Tyr in the gel (Cano et al., 1996) , and more recently, p90 Rsk-2 was puri®ed as the growth factor regulated CREB kinase on the basis of its ability to phosphorylate a CREB peptide in the gel (Xing et al., 1996) . In this report, by virtue of co-polymerizing SOS in the gel, two dierent kinase activities were found to renature and phosphorylate SOS in the gel; the p42 and p44 MAP kinases and the p90 Rsk-2 protein kinase. Our ®nding that both p90 Rsk and MAP kinase may be involved in SOS phosphorylation is interesting in light of the co-ordinate regulation of these kinases upon growth factor stimulation. Indeed, expression of the immediate early genes responsible for proliferative and dierentiation signals, is mediated in part by activation of a Ras-dependent kinase cascade which involves the sequential phosphorylation and activation of the protein kinases Raf, MEK, MAPK and Rsk (Wood et al., 1992; Blenis, 1993) . Once activated MAP kinase and p90 Rsk, which have been shown to form a complex in vivo (Scimeca et al., 1992; Hsiao et al., 1994) , can translocate to the nucleus (Chen et al., 1992) where they can eect changes in gene transcription. MAPK has been shown to phosphorylate and activate the transcription factor ELK-1 (Gille et al., 1992 (Gille et al., , 1995 , whereas p90 Rsk has been shown to phosphorylate the transcription factor fos (Chen et al., 1996) , and more recently CREB, a major cAMP-regulated transcription factor (Xing et al., 1996) . Therefore, although p90 Rsk was initially puri®ed on the basis of its ability to phosphorylate the ribosomal protein S6, this is not the physiological substrate for this kinase, but rather that of p70 S6 kinase (Chung et al., 1992) . To date, with the exception of CREB and fos, few physiological targets for p90 Rsk have been identi®ed. However, given the co-ordinate regulation and association of p90 Rsk and MAP kinase in vivo, a common functional role may be shared between these enzymes in the control of transcriptional regulation as well as in regulation of the Ras pathway. That is, in response to growth factor stimulation, a pool of MAPK and Rsk may be made to translocate to the nucleus where they can eect changes in trancriptional activity, while a distinct pool of the kinases may be made to translocate to the membrane where phosphorylation of the exchange factor SOS would contribute to regulation of the Ras pathway.
Consistent with both Rsk and MAP kinase being involved in SOS phosphorylation, the carboxy terminal tail of SOS contains a number of consensus sequences for both Rsk (R-X-X-S) and MAPK (P-X-S/T-P) which may be targets in vivo. As measured in three dierent assays, Rsk and MAPK could phosphorylate SOS: by in-gel kinase assays, in vitro kinase assays, and ®nally by in vivo phosphorylation of SOS in PC12 cells. Indeed most of the major in vivo phosphorylated SOS peptides could be accounted for by either Rsk or MAP kinase phosphorylation. Interestingly, one of the major in vivo phosphopeptides (peptide e) was a major peptide generated by Rsk phosphorylation in vitro. This phosphopeptide lies within proline-rich sequences in the carboxy-terminal region of SOS which have previously been shown to be responsible for the binding of SOS to the amino-terminal SH3 domain of Grb2 (Sastry et al., 1995) . The phosphorylation of these proline-rich sequences by Rsk may suggest an important functional role for this kinase in the down regulation response of SOS. Similarly, CorbalanGarcia et al. identi®ed the MAPK phosphorylation sites in the C-terminal domain of SOS and reported that mutation of these sites to alanine residues prevented the dissociation of the Grb2-SOS complex in response to serum stimulation (Corbalan-Garcia et al., 1996b) . However, this group as well as several others have reported that a kinase other than MAPK may be involved in SOS phosphorylation. Indeed the in vivo labelling of SOS has revealed that not all phosphorylation sites can be accounted for by MAPK, and that an additional kinase may be involved in SOS phosphorylation and regulation (Por®ri and McCormick, 1996; Corbalan-Garcia et al., 1996b; Rozakis-Adcock et al., 1995) . By overexpressing the MAP kinase phosphatase MKP-1, Holt et al. (1996a) identi®ed a MEK-dependent, Erkindependent kinase involved in SOS phosphorylation in a CHO cell line overexpressing the insulin receptor. The SOS kinase described by this group was found to elute in the¯ow through fractions of an anion exchange column and was discounted as being p90 Rsk on the basis that MAP kinase inhibition (by MKP-1 expression) also led to Rsk inhibition. The data presented here indicate that in PC12 cells, in addition to MAP kinase, p90 Rsk-2 is also a SOS kinase. The SOS kinase described here was also Rasand MEK-dependent however, in contrast to Holt et al. our kinase was Erk-dependent and eluted around 0.2 M NaCl on an anion exchange column. While the use of dierent cell lines could account for the dierences observed in the characteristics of the SOS kinases, the nature of the stimulus could also account for these dierences. Indeed the mechanism of down regulation of SOS in response to insulin and EGF diers remarkably. While insulin stimulation causes dissociation of the Grb2-SOS complex (CorbalanGarcia et al., 1996a; Waters et al., 1995b; Cherniack et al., 1995) , stimulation with EGF causes the dissociation of the Grb2-SOS complex from Shc or from the phosphorylated receptor (Rozakis- Adcock et al., 1995; Klarlund et al., 1995; Langlois et al., 1995; Por®ri and McCormick, 1996) . Holt et al. have suggested that the dierences in EGF-and insulininduced down regulation of SOS may be due to the membrane localization of the complex (Holt et al., 1996b) ; the sustained membrane localization of the Grb2-SOS complex during EGF signalling (as opposed to insulin signalling) may prevent its dissociation. Alternatively, the complexes formed at the membrane upon EGF or insulin stimulation may function to recruit a dierent subset of kinases, and possibly phosphatases, which in turn may function to aect the stability of these complexes. It is possible therefore, The in vitro phosphorylated substrates from Figure 5 were subjected to tryptic peptide mapping; (a) and (c) peptides maps generated from MAPK phosphorylation of Glu-SOS and Gst-SOS1A. (e), f, g) peptide maps generated from Rsk-2 phosphorylation of Glu-SOS, Gst-SOS1A and Gst-SOS70. (b and d), mix of Glu-SOS and Gst-SOS1A peptides phosphorylated by Rsk-2 and MAPK and (h) mix of Gst-SOS1A and Gst-SOS70 peptides phosphorylated by Rsk-2 Figure 8 The amino acid sequence of the carboxy tail of human SOS1 and relative position of the Gst-mSOS fusions. Murine SOS is identical to human SOS from the arginine at position 1131 (corresponding to 1134 in mouse). The Gst-SOS1A and -SOS70 fusions both start at mSOS 1135. Gst-SOS70 terminates at 1205, while Gst-SOS1A terminates with the stop codon. The proline rich regions involved in binding the SH3 domains of Grb2 are boxed in dark grey. The two putative Rsk consensus sites within this stretch are boxed in lighter grey and the targeted serine residue shown in bold type. The serine residues identi®ed by Corbalan-Garcia et al. (1996b) (Kohn et al., 1995; Marte et al., 1996) , but it diplays a phosphorylation consensus sequence reminiscent of that of p90 Rsk-2 (R-X-R-Y-Z-S-Hyd, where X is any amino acid, Y and Z are small amino acids other than glycine and Hyd is a bulky hydrophobic amino acid) (Alessi et al., 1996) . However, Akt is unlikely to be a kinase involved in SOS phosphorylation and down regulation since the puri®ed kinase was unable to phosphorylate the two dierent Gst fusions corresponding to the carboxyl terminal region of SOS (data not shown).
To date, the role of phosphorylation in the down regulation of SOS and the Ras pathway remains unclear. While phosphorylation of SOS in response to insulin or EGF stimulation correlates with complex formation, the eects on Ras activation are still unclear. Indeed several groups have shown that the kinetics of Ras activation are unaected by the phosphorylation state of SOS (Corbalan-Garcia et al., 1996a; Burgering et al., 1993; Klarlund et al., 1996; de Vries-Smits et al., 1995) , while still others have shown that treatment of dierent cell lines with the MEK inhibitor PD98059 (which blocks SOS phosphorylation), leads to sustained Ras activation. (Langlois et al., 1995; Waters et al., 1995a) . Since very low levels of the Shc-Grb2-SOS complex are required for maximal Ras activation, it is likely that regulation of the Ras pathway by SOS phosphorylation occurs in a more subtle way which can not be measured solely on the basis of the complexes which are formed at the membrane (de Vries-Smits et al., 1995) . Perhaps assessing the direct eects of SOS phosphorylation on its exchange activity towards Ras in vitro and in vivo may be a better re¯ection of the activation state of Ras. We are currently trying to address the net contributions of MAP kinase and Rsk to regulation of the Ras pathway through SOS exchange activity and site directed mutagenesis.
Materials and methods
Antibodies and Gst fusions
The Gst fusion to the full length carboxy terminal tail of SOS (Gst-SOS1A, residues 1135 ± 1336) has been described before (Egan et al., 1993) . The Gst fusion to the proximal residues of the carboxy terminal tail of SOS, (Gst-SOS70, residues 1135 ± 1205) was provided by I Gout and M Water®eld (Ludwig Institute for Cancer Research, London).
The Erk-2 polyclonal antibody used for immunodepletion has been described before by Marte et al. (1995) . The pan Erk and SOS-1 monoclonal antibodies were purchased from Transduction Laboratories (Lexington, KY). Puri®ed MAPK (star®sh p44mpk) was purchased from Upstate Biotechnology Incorporated (Lake Placid, NY) as well as the p70S6K and SOS-1/2 polyclonal antibodies. Partially puri®ed p90 Rsk-2 as well as a sheep polyclonal antibody raised against a peptide encompassing amino acids 605 to 627 of Rsk-2 were provided by Y Doza and P Cohen (MRC, University of Dundee, Scotland).
Cell culture and harvesting PC12 cells were cultured in Dulbecco's modi®ed Eagle's medium containing 10% horse serum and 5% foetal calf serum. For growth factor stimulation, cells which were 80% con¯uent were serum starved overnight in 0.4% serum and stimulated with EGF (Calbiochem) at 50 ng/ml for 2 min. Alternatively, the cells were pre-treated with the MEK activation inhibitor PD98059 (provided by AR Saltiel at Parke-Davis Pharmaceutical Research) at 40 mM for 10 min (30 mM stock in 1% dimethylsulfoxide) and then stimulated with EGF as above. A stable PC12 cell line overexpressing the dominant negative N17 Ras mutant has been described before by Rodriguez-Viciana et al. (1994) .
SF9 cells were maintained in Grace's supplemented insect medium (Gibco-BRL) and infected with baculovirus expressing Glu ± Glu epitope tagged hSOS1 (Glu ± SOS) (Por®ri et al., 1994) . After 48 h of infection, the cells were lysed and the SOS protein puri®ed over an anti-Glu ± Glu monoclonal antibody-protein G-sepharose anity column as described by Por®ri et al. (1994) .
Typically, cells were harvested on ice in lysis buer containing 50 mM HEPES, 100 mM NaCl, 1 mM EGTA, 1% Triton X-100, 2 mM NaF, 2 mM Na pyrophosphate, 0.5 mM sodium orthovanadate, 0.1 mg/ml phenylmethylsulfonyl¯uoride, 1 mM para-nitrophenylphosphate, and 10 mg/ ml of each leupeptin, pepstatin, and aprotinin. The lysates were cleared for 15 min at 15 000 r.p.m. and then loaded onto anion exchange chromatography columns, or used for immunoprecipitation.
In vivo labelling of SOS PC12 cells (10 cm dishes) were in vivo labelled overnight with 1 mCi/ml of [ 32 P] in 0.4% foetal calf serum. The following day, the cells were either left unstimulated, stimulated with EGF (100 ng/ml for 2 min) or pre-treated with PD98059 (40 mM for 10 min) and stimulated with EGF. After the cells were washed in cold PBS and lysed, the cleared lysates were immunoprecipitated with SOS antibodies (a mixture of Transduction Laboratories and UBI antibodies) for 2 h at 48C. Protein G-sepharose (Sigma) was added for a further 30 min and the immunoprecipitates extensively washed with PBS-(0.1%)Triton. The immunoprecipitates were resolved by 10% SDS ± PAGE, transferred to nitro-cellulose and autoradiographed.
Kinase assays and tryptic peptide mapping
In vitro kinase assays were carried out in a ®nal reaction volume of 25 ± 30 ml with 5 mg of substrate (either Glu-SOS, Gst-SOS1A, Gst-SOS70, Gst or MBP). Puri®ed p90 Rsk-2 (0.1 unit per assay), puri®ed MAPK (10 ng per assay) or 10 ml of fractions derived from the chromatography column were used as a source of kinase. The kinase buer consisted of 25 mM HEPES (pH 8.0), 10 mM MgCl 2 , 2 mM MnCl 2 and 10 mM cold ATP. Each kinase reaction contained 1 mCi of [g-32 P]ATP. For tryptic peptide mapping analysis, kinase reactions were transferred to nitro-cellulose, autoradiographed and bands cut out. Membrane pieces were digested with 1 mg of sequencing grade modi®ed trypsin (Promega, Madison, WI) overnight at 308C in 50 mM ammonium bicarbonate and 0.1% n-octyl b-D-glucopyranoside. After the overnight incubation, peptides were diluted in 500 ml of water and dried by Speed Vac. The peptides were then oxidized in 50 ml performic acid for 60 min on ice, diluted to 500 ml with water and dried by Speed Vac. Peptides were resolved by electrophoresis in pH 1.9 buer at 1000 volts for 60 min on the Hunter thin layer electrophoresis system (CBS Scienti®c company Inc., Del Mar, CA) and separated by chromatography in buer containing n-butanol (204 ml), acetic acid (50 ml), pyridine (143 ml) and water (143 ml) as adapted from Boyle et al. (1991) .
In gel kinase assays
In gel kinase assays were performed essentially as described by Cano et al. (1994) . Brie¯y, 30 mg of total cell lysate or alternatively, fractions obtained from anion exchange chromatography were resolved on 10% SDS polyacrylamide gels containing 200 mg/ml of either myelin basic protein (Sigma), or Glu-SOS (puri®ed from baculovirus infected SF9 cells). The gels were then washed for 60 min in 50 mM Tris-HCl (pH 8.0), 20% isopropanol to remove SDS (250 ml per mini-gel), and then in 50 mM Tris-HCl (pH 8.0) containing 1 mM DTT for another 60 min. Gels were denatured in 50 ± 100 ml of 6M guanidine-HCl (Calbiochem), 20 mM DTT, 2 mM EDTA, 50 mM TrisHCl (pH 8.0) for 60 min with gentle shaking, and then renatured overnight at 48C without agitation in 250 ml of 50 mM Tris-HCl (pH 8.0), 1 mM DTT, 2 mM EDTA, 0.04% Tween 20. For kinase assays, the gels were preincubated in kinase buer (40 mM HEPES (pH 8.0), 1 mM DTT, 20 mM MgCl 2 , 100 mM sodium orthovanadate) for 60 min and the assay performed in the same buer supplemented with 30 mM ATP, and 10 mCi/ml of [g-32 P]ATP for 60 min. Finally the gels were washed extensively in 5% TCA and 1% Na pyrophosphate, coomassie stained, dried and autoradiographed.
Anion exchange chromatography
PC12 cells were harvested in lysis buer as before except that NaCl was omitted from the lysis buer. The extracts were applied to a 5 ml Econo-Pac high Q cartridge (BioRad Laboratories, Hercules, CA) and proteins eluted with buer A (20 mM Tris-HCl (pH 7.5), 2 mM EDTA, 10 mM Benzamidine, 0.3% b-mercaptoethanol, 0.05% Triton X-100) at a¯ow rate of 1.0 ml/min with a discontinuous gradient (10 ml from 0 to 0.2 M NaCl, 20 ml from 0.2 to 0.4 M NaCl and 20 ml from 0.4 to 1.0 M NaCl). Fractions were analysed by in-gel kinase assay, by immunoblotting with pan Erk or anti-p90 Rsk-2 antibodies or by in vitro kinase assays using Glu-SOS as a substrate. For the experiment in Figure 2 , approximately 6 mg of total protein was loaded onto the column, whereas for Figure  3 , 14.4 mg of total lysate derived from each of the conditions (unstimulated PC12, EGF treated, PD98059 and EGF treated or N17-PC12 cells treated with EGF) was loaded onto the column.
Immunodepletion with Rsk antibodies
For immunodepletion, a chromatography fraction positive for the 90 kDa SOS in-gel kinase activity was immunoprecipitated with either anti-p90 Rsk-2, anti-p70S6K or anti-Erk-2 antibodies and protein G-sepharose as a control. 75 ml of a 1 ml fraction was diluted with 300 ml of lysis buer and incubated with 4 mg of each of the antibodies. The immunoprecipitations were carried out for 60 min followed by a 30 min incubation with protein Gsepharose (40 ml of a 1:1 slurry). After three sequential rounds of immunoprecipitation, both the immunoprecipitates and the remaining supernatants (25 ml of the 375) were assayed for SOS in-gel kinase activity (5 ml of the original fraction was also run for comparison).
